Overview

Does Fampridine SR Improve Cognitive Fatigue in Multiple Sclerosis Patients?

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
Multiple Sclerosis (MS) patients often complain of cognitive fatigue. There is currently no treatment for this symptom. Fampridine SR is a recently approved medication that improves walking ability and walking speed in MS patients. It is thought that it might have the same positive effect on cognitive fatigue. This study will compare fampridine 10mg twice a day to placebo in order to determine if there is any benefit of this medication for cognitive fatigue in MS.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
London Health Sciences Centre
Treatments:
4-Aminopyridine